Other Liabilities, Noncurrent of Verve Therapeutics, Inc. from 31 Dec 2020 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary: Verve Therapeutics, Inc. quarterly Other Liabilities, Noncurrent in USD history and change rate from 31 Dec 2020 to 31 Mar 2025.
Verve Therapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending 31 Mar 2025 was $70,000, a 58% decline year-over-year.
Source SEC data: View on sec.gov

Other Liabilities, Noncurrent, Quarterly (USD)

Other Liabilities, Noncurrent, YoY Quarterly Change (%)

Verve Therapeutics, Inc. Quarterly Other Liabilities, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$70,000	-$95,000	-58%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$95,000	-$94,000	-50%	31 Dec 2024	10-Q	14 May 2025	2025	Q1
Q3 2024	$118,000	-$95,000	-45%	30 Sep 2024	10-Q	05 Nov 2024	2024	Q3
Q2 2024	$142,000	-$94,000	-40%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$165,000	-$95,000	-37%	31 Mar 2024	10-Q	08 May 2024	2024	Q1
Q4 2023	$189,000	-$94,000	-33%	31 Dec 2023	10-K	27 Feb 2025	2024	FY
Q3 2023	$213,000			30 Sep 2023	10-Q	07 Nov 2023	2023	Q3
Q2 2023	$236,000			30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$260,000			31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$283,000	-$94,000	-25%	31 Dec 2022	10-K	27 Feb 2024	2023	FY
Q4 2021	$377,000	+$377,000		31 Dec 2021	10-K	02 Mar 2023	2022	FY
Q4 2020	$0			31 Dec 2020	10-K	14 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.